Revenue Dynamics YoY (Last Twelve Months): Virax Biolabs Corp (VRAX)

Public company logo of Virax Biolabs Corp (VRAX)

The 12-month YoY sales growth chart demonstrates the effectiveness of competent management within the rapid diagnostics niche amid cyclical revenue fluctuations for Virax Biolabs Group (VRAX). Current revenue relies on the inertia of local epidemics, creating volatility without long-term stability. The value of 96.00 reflects the latest metric, highlighting the potential of innovative portable laboratories that allow the company to exercise pricing power.

VRAX Virax Biolabs Corp: Revenue Growth YoY (Last 12 Months) in the range 02/11/2024 - 11/18/2026

Virax Biolabs (VRAX) - metric breakdowns and financial figures

- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
Summary company analytics:VRAX Virax Biolabs Corp
Brand item of viraxbiolabs.com

This indicator measures the daily change in aggregate revenue over a rolling year, allowing investors to filter out short-term volatility and assess the actual scalability of the business. By analyzing the year-over-year product sales dynamics for TTM, one can determine the commercialization efficiency of Virax Biolabs Group (VRAX) diagnostic systems for detecting viral infections and evaluate the demand stability for their immunological tests.

Competitors of Virax Biolabs Group (VRAX)

Agilent Corp (A) - Trailing Twelve Months Revenue Growth|DGX - Sales Growth YoY (Last Twelve Months)|ILMN: Sales Growth YoY (Last Twelve Months)|EXAS: Sales Growth YoY (TTM)|RVTY (Revvity) - Sales Growth YoY (Last Twelve Months)|BIO (Bio-Rad Laboratories, Inc.) - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Anbio Biotechnology NNNN|Revenue Growth YoY (Last 12 Months) SHC (Sotera Health Company)|Sales Growth YoY (Last Twelve Months) QDEL (quidel.com)|Sales Growth YoY (TTM) OPK (opko.com)|Revenue Dynamics YoY (Last Twelve Months) CDNA|MRVI: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) FLGT (Fulgent Corp)|LAB: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth cytekbio.com (CTKB)|OSUR (OraSure Corp) - Sales Growth YoY (TTM)|Exagen (XGN) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) MDxHealth, Inc. (MDXH)|Lucid Diagnostics, Inc - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (Last Twelve Months) Prenetics PRE|Insight Molecular (IMDX) - Trailing Twelve Months Revenue Growth|Trinity Biotech Corp - Sales Growth YoY (TTM)|Annual Revenue Growth (Last Twelve Months) ProPhase PRPH|AIMD: Sales Growth YoY (TTM)|CODX - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Heart Test Laboratories, Inc.|Sales Growth YoY (Last Twelve Months) BMRA|Sales Growth YoY (TTM) CDIO|Onconetix - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (TTM) BJDX (Bluejay Diagnostics Corp)|Aspira Women's Health - Sales Growth YoY (Last Twelve Months)|AXDX - Sales Growth YoY (Last Twelve Months)|Revenue Growth Rate YoY (Last Twelve Months) Centogene NV (CNTG)|ENZ (Enzo Biochem) - Revenue Growth YoY (Last 12 Months)|fresh2.co (FRES) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) Genetic Technologies Limited|Trailing Twelve Months Revenue Growth 23andMe Inc. ME|Sales Growth YoY (Last Twelve Months) Psychemedics (PMD)